Hanover Insurance (THG)

NYSE Financials Property & Casualty Insurance S&P MidCap 400
$242.90
-6.35 (-2.55%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+0.3%
1M+9.4%
3M+7.6%
6M+28.4%
YTD+32.9%
1Y+38.0%
3Y+103.2%
5Y+92.8%

Key statistics

Full financials →
Market cap$8.3B
P/E (TTM)11.6
EPS (TTM, diluted)$20.90
P/S1.22
P/B2.43
EV / EBITDA8.4
Revenue (TTM)$6.83B
Revenue growth+5.0%
Net margin11.0%
ROE21.8%
Debt / equity0.25
FCF yield14.6%
Dividend yield1.56%
Payout ratio18%
Beta (1Y)-0.19
Volatility (1Y)20.8%
52-week range$166.54 – $256.74
Avg volume (50D)297.16K

Revenue & net income — last 8 quarters

Statements →
Oct 28, 5:17 PM ET

Hanover Q3 operating EPS rises to $5.15 as net income dips to $4.86 per share

Mixed earnings 2.02

The Hanover Insurance Group reported third-quarter 2026 results, with net income of $172.6 million, or $4.86 per diluted share, down from $178.7 million, or $4.90, a year earlier. Operating income fell to $183.1 million from $185.6 million, but operating EPS rose to $5.15 from $5.09 because the share count declined, and the combined ratio worsened to 92.3% from 91.1% on higher catastrophe losses.

  • Net income of $172.6 million, or $4.86 per diluted share, versus $178.7 million, or $4.90, in the prior-year quarter
  • Operating income of $183.1 million, or $5.15 per diluted share, versus $185.6 million, or $5.09
  • Combined ratio of 92.3% versus 91.1%, with catastrophe losses of $109.7 million, or 6.8 points
  • Repurchased approximately $86 million of stock in the quarter, totaling $263 million year-to-date through October 26, 2026
Read the filing on SEC.gov ↗
Jul 28, 4:52 PM ET

Hanover posts record Q2 net income of $191.6 million, $5.38 per diluted share

Positive earnings Written later 2.02

The Hanover Insurance Group reported second-quarter 2026 net income of $191.6 million, or $5.38 per diluted share, up from $157.1 million, or $4.30, a year earlier. Operating income rose to $189.2 million, or $5.31 per share, from $158.7 million, or $4.35, and the combined ratio improved to 91.2% from 92.5%. CEO John C. Roche said he plans to retire at the end of 2026, a leadership change shareholders will track.

  • Net income $191.6 million ($5.38 per diluted share) vs. $157.1 million ($4.30) in Q2 2025
  • Operating income $189.2 million ($5.31 per diluted share) vs. $158.7 million ($4.35); combined ratio 91.2% vs. 92.5%
  • Roche plans to retire at the end of 2026; Dick Lavey named as a key figure in the transition
  • Company repurchased about $55 million of stock in Q2; about $660 million remains under a $700 million authorization
Read the filing on SEC.gov ↗
Jul 15, 5:13 PM ET

Hanover CEO Roche to retire December 31, 2026; COO Richard Lavey named CEO-elect

Neutral leadership Written later 5.02

The Hanover Insurance Group said CEO John C. Roche will retire as president, CEO and board member effective December 31, 2026. Chief Operating Officer Richard W. Lavey has been named CEO-elect and is expected to succeed Roche as CEO at that time, with a board seat from January 1, 2027. The filing reports no financial results, but it changes the company's top executive role.

  • John C. Roche, 62, retires as president, CEO and board member effective December 31, 2026, and stays as an advisor through January 8, 2027.
  • Richard W. Lavey, 59, has been Executive Vice President and Chief Operating Officer since March 2025 and is named CEO-elect.
  • The Board intends to elect Lavey to the Board effective January 1, 2027.
  • The company's earnings call is scheduled for July 29, 2026, and its investor day for September 17, 2026.
Read the filing on SEC.gov ↗
May 13, 4:12 PM ET

Hanover Insurance authorizes $700 million share buyback, replacing 2018 program

Positive shareholder Written later 5.025.078.01

The Hanover Insurance Group's board terminated its prior share repurchase program, which had about $63 million remaining, and approved a new authorization of up to $700 million in buybacks with no time limit. The company also named Patricia A. Norton-Gatto as principal accounting officer, replacing CFO Jeffrey M. Farber in that role, and shareholders re-elected eight directors at the May 12, 2026 annual meeting.

  • New share repurchase authorization of up to $700 million, with no time limit and no obligation to repurchase shares
  • Prior program, initially approved in December 2018, had about $63 million remaining and was terminated on May 13, 2026
  • Patricia A. Norton-Gatto, Senior Vice President and Corporate Controller, became principal accounting officer effective May 13, 2026
  • At the May 12, 2026 annual meeting, all eight directors were elected; Joseph R. Ramrath received 933,965 votes against
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own THG

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $15.05M0.02% New
Ray Dalio Bridgewater Associates $6.02M0.02% Added

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All THG congressional trades →
TradedMemberTypeAmount
May 12, 2025Jefferson Shreve IN-06Sell$15,001 – $50,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Nov 04Bunting Theodore H Jr
Director
Gift450—$0
Nov 04Lee Willard T
Executive Vice President
Sell9.95K$249.14$2.48M
Sep 25Ramrath Joseph R
Director
Award4—$0
Sep 25Lane Kathy S
Director
Award4—$0
Sep 25Egan Cynthia
Director
Award4—$0
Sep 25Donnell William E.
Director
Award4—$0
Sep 25Condrin J Paul
Director
Award4—$0
Sep 25Carlin Jane D
Director
Award4—$0
Sep 25Bunting Theodore H Jr
Director
Award4—$0
Sep 25Bradicich Kevin
Director
Award4—$0
Sep 25Aristeguieta Francisco
Director
Award4—$0
Sep 25Ward Elizabeth A
Director
Award4—$0

Prices are end-of-day and split-adjusted. Financial data from Hanover Insurance's SEC XBRL filings. Not investment advice.